Paper80453
Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
Ghose T and 1 other. J Natl Cancer Inst, 1978. Cited by 157 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. Papers, record 80453. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/80453
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Alkylating Agents | |
| Animals | |
| Antibiotics, Antineoplastic | |
| Antibody Specificity | |
| Antigens, Neoplasm | |
| Antimetabolites, Antineoplastic | |
| Bacterial Toxins | |
| Drug Resistance | |
| Epitopes | |
| Histocompatibility Antigens | |
| Humans | |
| Immunity | |
| Methods | |
| Phospholipases | |
| Plant Proteins |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,953,775 | Evolution of Pyrrolysyl-tRNA Synthetase: From Methanogenesis to Genetic Code Expansion. | Chem Rev | 2024 | https://conductscience.org/library/papers/38953775 | PubMed |
| 28,134,797 | Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research. | Molecules | 2017 | https://conductscience.org/library/papers/28134797 | PubMed |
| 18,508,155 | Use of antibodies and immunoconjugates for the therapy of more accessible cancers. | Adv Drug Deliv Rev | 2008 | https://conductscience.org/library/papers/18508155 | PubMed |
| 7,284,242 | A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7284242 | PubMed |
| 7,207,602 | Directing toxins to cancer cells. | Nature | 1981 | https://conductscience.org/library/papers/7207602 | PubMed |
| 6,996,771 | Monoclonal antibodies as tools in hematology. | Blut | 1980 | https://conductscience.org/library/papers/6996771 | PubMed |
| 6,988,099 | Oncostatic-antibody complexes in chemotherapy. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6988099 | PubMed |
| 6,968,912 | Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6968912 | PubMed |
| 6,952,214 | A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6952214 | PubMed |
| 6,950,410 | Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6950410 | PubMed |
| 6,925,984 | Inhibition of a mouse hepatoma by the alkylating agent Trenimon linked to immunoglobulins. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6925984 | PubMed |
| 6,821,632 | Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6821632 | PubMed |
| 6,804,591 | In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. | J Exp Med | 1982 | https://conductscience.org/library/papers/6804591 | PubMed |
| 6,586,198 | Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6586198 | PubMed |
| 6,350,169 | Cytotoxic effect of anti-idiotype antibody-chlorambucil conjugates against human lymphoblastoid cells. | Immunology | 1983 | https://conductscience.org/library/papers/6350169 | PubMed |
| 6,205,782 | Daunomycin-arachidonic acid complex as a potential new antitumor agent. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6205782 | PubMed |
| 6,183,764 | Human tumor-associated antigens identified by monoclonal antibodies. | Springer Semin Immunopathol | 1982 | https://conductscience.org/library/papers/6183764 | PubMed |
| 6,165,996 | Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6165996 | PubMed |
| 3,929,932 | Monoclonal antibodies in clinical medicine. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3929932 | PubMed |
| 3,847,291 | Conjugation of methotrexate to IgG antibodies and their F(ab)2 fragments and the effect of conjugated methotrexate on tumor growth in vivo. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3847291 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/80453
GET https://conductscience.org/api/papers/v1/80453/cited_by?page=2